We are live on ! Find out more
HYPR icon

Hyperfine

Positive
Neutral
Negative
Sentiment 3-Months
Positive 7.7%
Neutral 92.3%
Negative 0%

Neutral
Business Wire
21 days ago
Hyperfine Announces European Launch of Next-Generation Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine initiates the launch of the next-gen Swoop® system in Europe, beginning global expansion of its most advanced portable MRI technology. ‌.
Hyperfine Announces European Launch of Next-Generation Swoop® System
Neutral
Business Wire
1 month ago
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
GUILFORD, Conn.--(BUSINESS WIRE)--Leading neurosurgeons will help guide the role of the Swoop® system in neurosurgical care, including workflow, product capabilities, and evidence.
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
Neutral
Business Wire
1 month ago
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces Swoop® system scan volume milestones at key hospitals and neurology clinics, demonstrating accelerating adoption across the US.
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
Neutral
Seeking Alpha
1 month ago
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Neutral
Business Wire
1 month ago
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine is expected to join broad-market Russell 3000® Index & small-cap Russell 2000® Index at the conclusion of June 2026 Russell Reconstitution.
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
Neutral
Business Wire
2 months ago
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings.
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
Neutral
Seeking Alpha
2 months ago
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript
Neutral
MarketBeat
2 months ago
Hyperfine Q1 Earnings Call Highlights
Hyperfine NASDAQ: HYPR reported a sharp year-over-year increase in first-quarter revenue and reiterated its full-year 2026 outlook, as management pointed to continued adoption of its next-generation Swoop portable MRI system across hospitals, neurology offices and international markets.
Hyperfine Q1 Earnings Call Highlights
Positive
Zacks Investment Research
2 months ago
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.12 per share a year ago.
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Neutral
Business Wire
2 months ago
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2026 financial results and provided a business update. “Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating.
Hyperfine, Inc. Reports First Quarter 2026 Financial Results